Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5RBM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,369
Award facts
- Contract value 100% obligated
- $30,369.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,369.07 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The award, made on January 26, 2026, with an ultimate completion date of January 27, 2026, represents a firm fixed-price contract with no set-aside designation, indicating competitive award to this qualified vendor. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award vehicle valued at up to $999,999,999.00 through December 2026, which serves as the primary procurement mechanism for pharmaceutical supplies supporting military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., functions as a critical pharmaceutical distributor for federal medical procurement, particularly serving military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products across multiple therapeutic domains, including diabetes medications, specialty treatments, vaccines, and medical supplies. As the prime vendor under the DLA Troop Support Medical contract vehicle, AmerisourceBergen demonstrates significant capability in fulfilling government requirements for essential prescription medications required by military treatment facilities and federal health programs.
Quick answers
Who was awarded contract SPE2DR26F5RBM?
SPE2DR26F5RBM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F5RBM worth?
The government has obligated $30,369 on SPE2DR26F5RBM.
Is contract SPE2DR26F5RBM an order under another contract?
Yes. SPE2DR26F5RBM is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5RBM competed?
The extent of competition for SPE2DR26F5RBM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award